Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience-Reference-Cited by-同舟云学术

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience

Published:2017-11-29 Issue:8 Volume:59 Page:1861-1870
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Giulino-Roth Lisa¹²,O’Donohue Tara¹²,Chen Zhengming³,Trippett Tanya M.²,Klein Elizabeth²,Kernan Nancy A.²,Kobos Rachel²,Prockop Susan E.²,Scaradavou Andromachi²,Shukla Neerav²,Steinherz Peter G.²,Moskowitz Alison J.⁴,Moskowitz Craig H.⁴,Boulad Farid¹²

Affiliation:

1. Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA;

2. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

3. Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, USA;

4. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1403601

Reference41 articles.